Company: INSP
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001609550-25-000032
Chunk: 20

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 20
---
 market funds, are stated at fair value.Foreign CurrencyOur functional and reporting currency is the U.S. dollar. Our subsidiaries have functional currency in Euro and Yen. The consolidated financial statements are translated to U.S. dollars. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other expense, net in the consolidated statements of operations and comprehensive income (loss). For the three-month periods ended June 30, 2025 and 2024, we recognized $0.5 

10

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

million of gain and $0.1 million of loss, net, respectively. For the six-month periods ended June 30, 2025 and 2024 we recognized $1.1 million of gain and $0.2 million of loss, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $0.1 million and $0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of June 30, 2025 and December 31, 2024, respectively.InvestmentsOur investments are classified as available-for-sale and consisted of the following:June 30, 2025AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$21,657 $15 $— $21,672 Corporate debt securities26,498 42 (1)26,539 Certificates of deposit2,994 1 — 2,995 U.S. treasury debt securities142,764 59 (61)142,762 Short-term investments$193,913 $117 $(62)$193,968 Long-Term:Corporate debt securities$49,972 $168 $(6)$50,134 Asset-backed securities32 — — 32 U.S. treasury debt securities59,541 123 —